Usual Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin on Coronary Atherosclerotic Plaque
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
The aim of this prospective, open-label, randomized, single center study is to compare the
effect of usual dose rosuvastatin plus ezetimibe and high-dose rosuvastatin on modifying
atherosclerotic plaque.